Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03699540 · ClinicalTrials.gov registry record · Phase 1

Marijuana Effects on Simulated Driving Performance

A Phase 1 study, sponsored by Shanna Babalonis, PhD.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target

NCT03699540 is a Phase 1 study that has completed, run by Shanna Babalonis, PhD. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03699540, a Phase 1 study, has completed, sponsored by Shanna Babalonis, PhD.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

This study will examine the effects of various strains of marijuana on simulated driving performance; the effects of alcohol administration will also be examined to further understand how marijuana-induced driving changes compare to the effects of alcohol. Secondary outcomes will include physiological effects, subjective- and observer-rated outcomes, and psychomotor performance under the various dose conditions.

Interventions

  • DRUG Alcohol
  • DRUG Marijuana
  • DRUG placebo alcohol
  • DRUG Inactive marijuana

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-07-01
Est. Completion 2023-01-01
Phase Phase 1

Sponsor

Shanna Babalonis, PhD

6 total trials

What the Registry Record Tells You About NCT03699540

The ClinicalTrials.gov registry entry for NCT03699540 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shanna Babalonis, PhD, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Alcohol is the first listed.

NCT03699540 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03699540 about?

NCT03699540 is a clinical study titled "Marijuana Effects on Simulated Driving Performance". This study will examine the effects of various strains of marijuana on simulated driving performance; the effects of alcohol administration will also be examined to further understand how marijuana-induced driving changes compare to the effects of alcohol. Secondary outcomes will include physiologic...

What is the current status of trial NCT03699540?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-07-01. Estimated completion is 2023-01-01.

What interventions are being tested in trial NCT03699540?

The interventions under investigation include: Alcohol (DRUG), Marijuana (DRUG), placebo alcohol (DRUG), Inactive marijuana (DRUG).

Who is sponsoring clinical trial NCT03699540?

This trial is sponsored by Shanna Babalonis, PhD, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.